Strs Ohio Sells 6,600 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD)

Strs Ohio reduced its holdings in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) by 8.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 69,700 shares of the company’s stock after selling 6,600 shares during the quarter. Strs Ohio’s holdings in Viemed Healthcare were worth $547,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Ulland Investment Advisors LLC bought a new position in shares of Viemed Healthcare in the third quarter valued at $85,000. DORCHESTER WEALTH MANAGEMENT Co bought a new position in shares of Viemed Healthcare in the third quarter valued at $84,000. Mackenzie Financial Corp bought a new position in shares of Viemed Healthcare in the third quarter valued at $89,000. Punch & Associates Investment Management Inc. grew its stake in shares of Viemed Healthcare by 3.7% in the third quarter. Punch & Associates Investment Management Inc. now owns 510,085 shares of the company’s stock valued at $3,433,000 after buying an additional 18,270 shares in the last quarter. Finally, Panagora Asset Management Inc. grew its stake in shares of Viemed Healthcare by 58.7% in the third quarter. Panagora Asset Management Inc. now owns 82,768 shares of the company’s stock valued at $557,000 after buying an additional 30,626 shares in the last quarter. 74.24% of the stock is owned by institutional investors.

Viemed Healthcare Price Performance

NASDAQ:VMD opened at $8.31 on Friday. The company has a current ratio of 1.19, a quick ratio of 1.05 and a debt-to-equity ratio of 0.05. The firm has a fifty day simple moving average of $8.79 and a 200 day simple moving average of $8.03. Viemed Healthcare, Inc. has a 1-year low of $5.90 and a 1-year high of $11.27. The stock has a market capitalization of $322.10 million, a PE ratio of 31.96 and a beta of 1.51.

Viemed Healthcare (NASDAQ:VMD) last released its quarterly earnings data on Wednesday, March 6th. The company reported $0.09 EPS for the quarter. Viemed Healthcare had a net margin of 5.60% and a return on equity of 9.59%. The firm had revenue of $50.74 million during the quarter.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.